Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |